These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9635912)

  • 21. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations.
    Negri MC; Morosini MI; Loza E; Baquero F
    Antimicrob Agents Chemother; 1994 Jan; 38(1):122-5. PubMed ID: 8141563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J; Zhang Y; Chen Y; Hao F; Chen Y
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
    Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.
    Barry AL; Fuchs PC
    J Clin Microbiol; 1995 Apr; 33(4):1031-3. PubMed ID: 7790431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
    Nagai K; Matsuo Y; Tsumura N; Sakata Y; Kato H
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):107-13. PubMed ID: 10863105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in-vitro activity of penicillin alone and combined with gentamicin against clinical isolates of Streptococcus pneumoniae with decreased susceptibility to penicillin.
    Anadiotis L; Maskell JP; Sefton AM
    Int J Antimicrob Agents; 2002 Mar; 19(3):173-81. PubMed ID: 11932138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM; Biedenbach DJ; Beach ML; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
    Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
    J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
    Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
    J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
    Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
    Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of acute otitis media caused by resistant pneumococci in infants.
    Roger G; Carles P; Pangon B; Thien HV; Polonovski JM; Begue P; Garabedian EN
    Pediatr Infect Dis J; 1998 Jul; 17(7):631-8. PubMed ID: 9686731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN; Biedenbach DJ; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):573-8. PubMed ID: 9764398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms.
    Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A
    J Chemother; 2001 Aug; 13(4):402-6. PubMed ID: 11589483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.